604P Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer who progressed after prior VEGFR-targeted therapy: Outcomes from COSMIC-311 by BRAF status.
Saved in:
| Title: | 604P Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer who progressed after prior VEGFR-targeted therapy: Outcomes from COSMIC-311 by BRAF status. |
|---|---|
| Authors: | Brose, M.S.1 (AUTHOR), Keam, B.2 (AUTHOR), Robinson, B.3 (AUTHOR), Sherman, S.4 (AUTHOR), Krajewska, J.A.5 (AUTHOR), Lin, C-C.6 (AUTHOR), Vaisman, F.7 (AUTHOR), Hoff, A.O.8 (AUTHOR), Hitre, E.9 (AUTHOR), Bowles, D.W.10 (AUTHOR), Ngamphaiboon, N.11 (AUTHOR), Guo, X.12 (AUTHOR), Zhang, F.12 (AUTHOR), Schwickart, M.12 (AUTHOR), Williamson, D.S.13 (AUTHOR), Curran, D.14 (AUTHOR), Berry, N.15 (AUTHOR), Capdevila Castillon, J.16 (AUTHOR) |
| Source: | Annals of Oncology. 2023 Supplement 4, Vol. 34, pS1708-S1709. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 173758202 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 604P Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer who progressed after prior VEGFR-targeted therapy: Outcomes from COSMIC-311 by BRAF status. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Brose%2C+M%2ES%2E%22">Brose, M.S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Keam%2C+B%2E%22">Keam, B.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Robinson%2C+B%2E%22">Robinson, B.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sherman%2C+S%2E%22">Sherman, S.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Krajewska%2C+J%2EA%2E%22">Krajewska, J.A.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lin%2C+C-C%2E%22">Lin, C-C.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vaisman%2C+F%2E%22">Vaisman, F.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hoff%2C+A%2EO%2E%22">Hoff, A.O.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hitre%2C+E%2E%22">Hitre, E.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bowles%2C+D%2EW%2E%22">Bowles, D.W.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ngamphaiboon%2C+N%2E%22">Ngamphaiboon, N.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Guo%2C+X%2E%22">Guo, X.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+F%2E%22">Zhang, F.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schwickart%2C+M%2E%22">Schwickart, M.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Williamson%2C+D%2ES%2E%22">Williamson, D.S.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Curran%2C+D%2E%22">Curran, D.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Berry%2C+N%2E%22">Berry, N.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Capdevila+Castillon%2C+J%2E%22">Capdevila Castillon, J.</searchLink><relatesTo>16</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2023 Supplement 4, Vol. 34, pS1708-S1709. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=173758202 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2023.10.319 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S1708 Titles: – TitleFull: 604P Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer who progressed after prior VEGFR-targeted therapy: Outcomes from COSMIC-311 by BRAF status. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Brose, M.S. – PersonEntity: Name: NameFull: Keam, B. – PersonEntity: Name: NameFull: Robinson, B. – PersonEntity: Name: NameFull: Sherman, S. – PersonEntity: Name: NameFull: Krajewska, J.A. – PersonEntity: Name: NameFull: Lin, C-C. – PersonEntity: Name: NameFull: Vaisman, F. – PersonEntity: Name: NameFull: Hoff, A.O. – PersonEntity: Name: NameFull: Hitre, E. – PersonEntity: Name: NameFull: Bowles, D.W. – PersonEntity: Name: NameFull: Ngamphaiboon, N. – PersonEntity: Name: NameFull: Guo, X. – PersonEntity: Name: NameFull: Zhang, F. – PersonEntity: Name: NameFull: Schwickart, M. – PersonEntity: Name: NameFull: Williamson, D.S. – PersonEntity: Name: NameFull: Curran, D. – PersonEntity: Name: NameFull: Berry, N. – PersonEntity: Name: NameFull: Capdevila Castillon, J. IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 11 Text: 2023 Supplement 4 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 34 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |